1LCID Fundamental Analysis - LUCID GROUP INC

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to 1LCID. 1LCID was compared to 32 industry peers in the Automobiles industry. 1LCID has a bad profitability rating. Also its financial health evaluation is rather negative. 1LCID is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year 1LCID has reported negative net income.

1LCID had a negative operating cash flow in the past year.

1LCID had negative earnings in each of the past 5 years.

1LCID had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -35.61%, 1LCID is not doing good in the industry: 89.29% of the companies in the same industry are doing better.

The Return On Equity of 1LCID (-84.43%) is worse than 89.29% of its industry peers.

		Industry Rank	Sector Rank
ROA	-35.61%
ROE	-84.43%
ROIC	N/A

ROA(3y)-32.48%

ROA(5y)-41.59%

ROE(3y)-58.77%

ROE(5y)-71.55%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

1LCID does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

1LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.

1LCID has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, 1LCID has more shares outstanding

The debt/assets ratio for 1LCID has been reduced compared to a year ago.

2.2 Solvency

1LCID has an Altman-Z score of -2.72. This is a bad value and indicates that 1LCID is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of 1LCID (-2.72) is worse than 78.57% of its industry peers.

1LCID has a Debt/Equity ratio of 0.66. This is a neutral value indicating 1LCID is somewhat dependend on debt financing.

The Debt to Equity ratio of 1LCID (0.66) is better than 64.29% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.66
Debt/FCF	N/A
Altman-Z	-2.72

ROIC/WACCN/A

WACC7.37%

2.3 Liquidity

1LCID has a Current Ratio of 1.81. This is a normal value and indicates that 1LCID is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Current ratio value of 1.81, 1LCID is doing good in the industry, outperforming 75.00% of the companies in the same industry.

1LCID has a Quick Ratio of 1.34. This is a normal value and indicates that 1LCID is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.34, 1LCID is in the better half of the industry, outperforming 75.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.81
Quick Ratio	1.34

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.94% over the past year.

1LCID shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.86%.

1LCID shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 181.26% yearly.

EPS 1Y (TTM)20.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.36%

Revenue 1Y (TTM)45.86%

Revenue growth 3Y210.02%

Revenue growth 5Y181.26%

Sales Q2Q%68.26%

3.2 Future

Based on estimates for the next years, 1LCID will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.55% on average per year.

1LCID is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 65.29% yearly.

EPS Next Y8.81%

EPS Next 2Y16.51%

EPS Next 3Y15.66%

EPS Next 5Y13.55%

Revenue Next Year66.51%

Revenue Next 2Y75.43%

Revenue Next 3Y85.99%

Revenue Next 5Y65.29%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

1LCID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1LCID. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as 1LCID's earnings are expected to grow with 15.66% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y16.51%

EPS Next 3Y15.66%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

1LCID does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

LUCID GROUP INC

BIT:1LCID (12/23/2025, 7:00:00 PM)

9.982

-4.91 (-32.99%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupAutomobiles & Components

GICS IndustryAutomobiles

Earnings (Last)11-05 2025-11-05/amc

Earnings (Next)02-23 2026-02-23/amc

Inst Owners72.3%

Inst Owner ChangeN/A

Ins Owners0.21%

Ins Owner ChangeN/A

Market Cap3.24B

Revenue(TTM)1.07B

Net Income(TTM)-3.14B

Analysts51

Price Target20.09 (101.26%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-12.92%

Min EPS beat(2)-14.47%

Max EPS beat(2)-11.38%

EPS beat(4)2

Avg EPS beat(4)0.86%

Min EPS beat(4)-14.47%

Max EPS beat(4)15.08%

EPS beat(8)4

Avg EPS beat(8)-1.41%

EPS beat(12)6

Avg EPS beat(12)-1.65%

EPS beat(16)9

Avg EPS beat(16)2.27%

Revenue beat(2)0

Avg Revenue beat(2)-11.04%

Min Revenue beat(2)-12.96%

Max Revenue beat(2)-9.12%

Revenue beat(4)1

Avg Revenue beat(4)-5.55%

Min Revenue beat(4)-12.96%

Max Revenue beat(4)7.31%

Revenue beat(8)3

Avg Revenue beat(8)-3.4%

Revenue beat(12)3

Avg Revenue beat(12)-9.66%

Revenue beat(16)4

Avg Revenue beat(16)-11.4%

PT rev (1m)-6.83%

PT rev (3m)N/A

EPS NQ rev (1m)-6.82%

EPS NQ rev (3m)-4.99%

EPS NY rev (1m)-23.71%

EPS NY rev (3m)-23.86%

Revenue NQ rev (1m)4.32%

Revenue NQ rev (3m)10.72%

Revenue NY rev (1m)0.68%

Revenue NY rev (3m)-0.22%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.57
P/FCF	N/A
P/OCF	N/A
P/B	1.02
P/tB	1.02
EV/EBITDA	N/A

EPS(TTM)-7.87

EYN/A

EPS(NY)-5.96

Fwd EYN/A

FCF(TTM)-8.88

FCFYN/A

OCF(TTM)-6.69

OCFYN/A

SpS2.8

BVpS9.77

TBVpS9.77

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-35.61%
ROE	-84.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-32.48%

ROA(5y)-41.59%

ROE(3y)-58.77%

ROE(5y)-71.55%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	0.66
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	198.67%
Cap/Sales	78.3%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.81
Quick Ratio	1.34
Altman-Z	-2.72

F-Score5

WACC7.37%

ROIC/WACCN/A

Cap/Depr(3y)421.76%

Cap/Depr(5y)1286.62%

Cap/Sales(3y)146.37%

Cap/Sales(5y)2710.34%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)20.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.36%

EPS Next Y8.81%

EPS Next 2Y16.51%

EPS Next 3Y15.66%

EPS Next 5Y13.55%

Revenue 1Y (TTM)45.86%

Revenue growth 3Y210.02%

Revenue growth 5Y181.26%

Sales Q2Q%68.26%

Revenue Next Year66.51%

Revenue Next 2Y75.43%

Revenue Next 3Y85.99%

Revenue Next 5Y65.29%

EBIT growth 1Y-4.04%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year15.63%

EBIT Next 3Y17.43%

EBIT Next 5Y15.46%

FCF growth 1Y5.81%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y4.32%

OCF growth 3YN/A

OCF growth 5YN/A

LUCID GROUP INC / 1LCID.MI FAQ

What is the fundamental rating for 1LCID stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1LCID.MI.

What is the valuation status for 1LCID stock?

ChartMill assigns a valuation rating of 0 / 10 to LUCID GROUP INC (1LCID.MI). This can be considered as Overvalued.

What is the profitability of 1LCID stock?

LUCID GROUP INC (1LCID.MI) has a profitability rating of 0 / 10.

Can you provide the financial health for 1LCID stock?

The financial health rating of LUCID GROUP INC (1LCID.MI) is 4 / 10.

LUCID GROUP INC (1LCID.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

LUCID GROUP INC / 1LCID.MI FAQ

What is the fundamental rating for 1LCID stock?

What is the valuation status for 1LCID stock?

What is the profitability of 1LCID stock?

Can you provide the financial health for 1LCID stock?